Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
07 10 2020
Historique:
received: 01 03 2020
accepted: 09 09 2020
entrez: 8 10 2020
pubmed: 9 10 2020
medline: 24 6 2021
Statut: ppublish

Résumé

Tinnitus is a phantom auditory perception coded in the brain that can be bothersome or debilitating, affecting 10 to 15% of the population. Currently, there is no clinically recommended drug or device treatment for this major health condition. Animal research has revealed that sound paired with electrical somatosensory stimulation can drive extensive plasticity within the brain for tinnitus treatment. To investigate this bimodal neuromodulation approach in humans, we evaluated a noninvasive device that delivers sound to the ears and electrical stimulation to the tongue in a randomized, double-blinded, exploratory study that enrolled 326 adults with chronic subjective tinnitus. Participants were randomized into three parallel arms with different stimulation settings. Clinical outcomes were evaluated over a 12-week treatment period and a 12-month posttreatment phase. For the primary endpoints, participants achieved a statistically significant reduction in tinnitus symptom severity at the end of treatment based on two commonly used outcome measures, Tinnitus Handicap Inventory (Cohen's

Identifiants

pubmed: 33028707
pii: 12/564/eabb2830
doi: 10.1126/scitranslmed.abb2830
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Brendan Conlon (B)

Neuromod Devices Limited, Dublin D08 R2YP, Ireland.
School of Medicine, Trinity College, Dublin D02 R590, Ireland.
Department of Otolaryngology, St. James's Hospital, Dublin D08 NHY1, Ireland.

Berthold Langguth (B)

Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg 93053, Germany.
Interdisciplinary Tinnitus Center of University of Regensburg, Regensburg 93053, Germany.

Caroline Hamilton (C)

Neuromod Devices Limited, Dublin D08 R2YP, Ireland.

Stephen Hughes (S)

Neuromod Devices Limited, Dublin D08 R2YP, Ireland.

Emma Meade (E)

Neuromod Devices Limited, Dublin D08 R2YP, Ireland.

Ciara O Connor (CO)

Neuromod Devices Limited, Dublin D08 R2YP, Ireland.

Martin Schecklmann (M)

Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg 93053, Germany.
Interdisciplinary Tinnitus Center of University of Regensburg, Regensburg 93053, Germany.

Deborah A Hall (DA)

National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham NG7 2UH, UK.
Hearing Sciences, Division of Clinical Neuroscience, University of Nottingham, Nottingham NG7 2RD, UK.
University of Nottingham Malaysia, Selangor 43500, Malaysia.

Sven Vanneste (S)

Lab for Clinical and Integrative Neuroscience, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX 75080, USA.
Global Brain Health Institute, Trinity College Dublin, Dublin D02 PN40, Ireland.

Sook Ling Leong (SL)

Neuromod Devices Limited, Dublin D08 R2YP, Ireland.
Global Brain Health Institute, Trinity College Dublin, Dublin D02 PN40, Ireland.

Thavakumar Subramaniam (T)

Department of Otolaryngology, St. James's Hospital, Dublin D08 NHY1, Ireland.

Shona D'Arcy (S)

Neuromod Devices Limited, Dublin D08 R2YP, Ireland.

Hubert H Lim (HH)

Neuromod Devices Limited, Dublin D08 R2YP, Ireland. hubert.lim@neuromoddevices.com.
Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, MN 55455, USA.
Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH